China's tobacco smoking epidemic: prevalence, illness load, obstacles, and future plans

Authors

  • Abdul Rasool Khoso PhD Student
  • GU Jintu
  • Shahnaz Bhutto
  • Ling Li
  • Floria Lfeoma Ujuagu

Keywords:

Smoking Epidemic, Prevalence, Diseases, Obstacles and Future Plans, China

Abstract

China accounts for almost one-third of worldwide tobacco production and consumption, and despite current tobacco control efforts, the smoking rate remains frighteningly high, with 350 million smokers and 740 million passive smokers. Alarmingly, more young people and women are becoming smokers. With 1.2 million fatalities linked to tobacco use each year, the related mortality rate is startling, and estimates indicate that number will rise to 2 million by 2025. The tobacco industry's strong opposition, sociocultural factors that encourage smoking start, a lack of public knowledge about the dangers of smoking, and insufficient government backing are all blamed for the ineffectiveness of the present tobacco control policies. Government commitments are required in order to carry out effective and urgent intervention activities. It is imperative to take comprehensive action at several levels, such as lowering the availability of tobacco products, raising taxes on tobacco products, improving public health education, restricting tobacco advertising, lowering secondhand smoke exposure, and offering strong support for quitting smoking. To address this important public health issue, the healthcare community should take the lead in anti-tobacco initiatives and actively participate in smoking cessation programs.

References

Perrault R, Clark J. Artificial Intelligence Index Report. 2024.

Parascandola M, Xiao L. Tobacco and the lung cancer epidemic in China. Transl Lung Cancer Res. 2019;8(Suppl 1).

Staia MH, Cabrera EP, Iost A, Zairi A, Belayer S, Van Gorp A. Tribological response of AA 2024-T3 aluminium alloy coated with a DLC duplex coating. Tribol Int. 2015;85:74-87.

Leventhal AM, Dai H, Higgins ST. Smoking cessation prevalence and inequalities in the United States: 2014-2019. J Natl Cancer Inst. 2022;114(3):381-90.

Rasool SF, Wang M, Tang M, Saeed A, Iqbal J. How toxic workplace environment effects the employee engagement: The mediating role of organizational support and employee wellbeing. Int J Environ Res Public Health. 2021;18(5):2294.

Luo Q, Liu Y, Bi M, Kuai X, Tian Q, Sun Y, Zhuang S. Taste mapping: navigating the spatiotemporal link between diet and colorectal cancer. IEEE Access. 2024.

Seo W, Kim HW, Kim JS, Min J. Long term management of people with post-tuberculosis lung disease. Korean J Intern Med. 2024;39(1):7.

Hansen MS, Licaj I, Braaten T, Lund E, Gram IT. The fraction of lung cancer attributable to smoking in the Norwegian Women and Cancer (NOWAC) Study. Br J Cancer. 2021;124(3):658-62.

Wu W, Zhang R, Jin Y, Lu Y, Lu Z, Li T, Ye L, Lin L, Wei Y. Cancer trends and risk factors in China over the past 30 years (1990-2019). J Cancer. 2023;14(10):1935.

Alzahrani SH. Levels and factors of knowledge about the related health risks of exposure to secondhand smoke among medical students: A cross-sectional study in Jeddah, Saudi Arabia. Tob Induc Dis. 2020;18.40.

Zhang G, Zhan J, Fu H. Trends in smoking prevalence and intensity between 2010 and 2018: implications for tobacco control in China. Int J Environ Res Public Health. 2022;19(2):670.

Rigotti NA, Kruse GR, Livingstone-Banks J, Hartmann-Boyce J. Treatment of tobacco smoking: a review. JAMA. 2022;327(6):566-77.

Wang L, Lubin JH, Zhang SR, Metayer C, Xia Y, Brenner A, Shang B, Wang Z, Kleinerman RA. Lung cancer and environmental tobacco smoke in a nonâ€industrial area of China. Int J Cancer. 2000;88(1):139-45.

Wen H, Xie C, Wang F, Wu Y, Yu C. Trends in disease burden attributable to tobacco in China, 1990–2017: Findings from the global burden of disease study 2017. Front Public Health. 2020;8:237.

Dai S. Environmental Tobacco Smoke Exposure in Hong Kong Paediatric Population: Prevalence, Impact and Intervention (Doctoral dissertation, The Chinese University of Hong Kong (Hong Kong)).

World Health Organization. WHO report on the global tobacco epidemic, 2023: protect people from tobacco smoke. World Health Organ. 2023.

Koronaiou K, Al-Lawati JA, Sayed M, Alwadey AM, Alalawi EF, Almutawaa K, et al. Economic cost of smoking and secondhand smoke exposure in the Gulf Cooperation Council countries. Tob Control. 2021;30(6):680-6.

Rahmani R, Nakhaee S, Sharafi K, Rezaei Z, Mansouri B, Amirabadizadeh A. Association of environmental tobacco smoke (ETS) with lead and cadmium concentrations in biological samples of children and women: systematic review and meta-analysis. Rev Environ Health. 2024;39(1):13-25.

Obiagu AN, Onele AV. Prevalence and causes of drug abuse among youth-recipients of school-based drug education programs: A mixed-method study. Can J Fam Youth. 2024;16(1):16-37.

Xu F, Yin X, Zhang M, Shen H, Lu L, Xu Y. Prevalence of physician-diagnosed COPD and its association with smoking among urban and rural residents in regional mainland China. Chest. 2005;128(4):2818-23.

World Health Organization. WHO report on the global tobacco epidemic, 2008: the MPOWER package. World Health Organization; 2008.

World Health Organization. Tobacco and its environmental impact: an overview. World Health Organization; 2017.

World Health Organization. WHO framework convention on tobacco control: guidelines for implementation of article 5. 3, Articles 8 To 14. World Health Organization; 2013.

Park B, Kim Y, Lee J, Lee N, Jang SH. Sex difference and smoking effect of lung cancer incidence in Asian population. Cancers. 2020;13(1):113.

Chen J, Li X, Fang P. Influence of family resources on secondhand smoking in pregnant women: a cross-sectional study in the border and minority urban areas of Northwest China. BMC Pregnancy Childbirth. 2020;20:1-0.

Andriani H, Rahmawati ND, Ahsan A, Kusuma D. Second-hand smoke exposure inside the house and adverse birth outcomes in Indonesia: Evidence from Demographic and Health Survey 2017. medRxiv. 2021:11.

Shu CC, Tsai MK, Lee JH, Su TC, Wen CP. Mortality risk in patients with preserved ratio impaired spirometry: assessing the role of physical activity. QJM. 2024;hcae010.

Ang L, Ghosh P, Seow WJ. Association between previous lung diseases and lung cancer risk: a systematic review and meta-analysis. Carcinogenesis. 2021;42(12):1461-74.

Masvosva B. Prevalence of non-communicable diseases risk factors among administrative staff at a higher education institution in South Africa.

Ding L, Liang Y, Tan EC, Hu Y, Zhang C, Liu Y. Smoking, heavy drinking, physical inactivity, and obesity among middle-aged and older adults in China: cross-sectional findings from the baseline survey of CHARLS 2011–2012. BMC Public Health. 2020;20:1-9.

Gan Q, Smith KR, Hammond SK, Hu TW. Disease burden of adult lung cancer and ischaemic heart disease from passive tobacco smoking in China. Tobacco Control. 2007;16(6):417-22.

Muza LC. Knowledge, attitude and practices of health care providers on smoking cessation intervention–a case of Sol Plaajtie Subdistrict, Northern Cape.

Li W, Xue X, Li D, Zhang Y, Shen W, Pan Y, et al. Attributable fraction of tobacco smoking on selected cancer deaths in the past decade using mortality case-control study in Tianjin, China. Tob Induc Dis. 2022;20.

Jiang Y, Zhou X, Cheng L, Li M. The impact of smoking on subgingival microflora: from periodontal health to disease. Front. Microbiol. 2020;11:66.

Sun D, Li H, Cao M, He S, Lei L, Peng J, Chen W. Cancer burden in China: trends, risk factors and prevention. Cancer Bio Med. 2020;17(4):879.

World Health Organization. WHO global report on trends in prevalence of tobacco use 2000-2025. World Health Organization;2020.

Grundy EJ, Suddek T, Filippidis FT, Majeed A, Coronini-Cronberg S. Smoking, SARS-CoV-2 and COVID-19: A review of reviews considering implications for public health policy and practice. Tob Induc Dis. 2020;18.

Jin J. Why FCTC policies have not been implemented in China: domestic dynamics and tobacco governance. J Health Polit Policy Law. 2014;39(3):633-66.

Liu S, Zhang M, Yang L, Li Y, Wang L, Huang Z, Wang L, Chen Z, Zhou M. Prevalence and patterns of tobacco smoking among Chinese adult men and women: findings of the 2010 national smoking survey. J Epidemiol Community Health. 2017;71(2):154-61.

Barnett R, Jiang S, Peng S. Evaluating China’s record of tobacco control. InSmoking Environments in China: Challenges for Tobacco Control. 2021;247-285. Cham: Springer International Publishing.

Li C. The political mapping of China's tobacco industry and anti-smoking campaign. John L. Thornton China Center at Brookings; 2012.

Ranabhat CL, Kim CB, Park MB, Jakovljevic M. Situation, impacts, and future challenges of tobacco control policies for youth: an explorative systematic policy review. Front Pharmacol. 2019;10:981.

Yach D, Hawkes C, Gould CL, Hofman KJ. The global burden of chronic diseases: overcoming impediments to prevention and control. J Am Med Assoc. 2004;291(21):2616-22.

Liu Y, Dai M, Bi Y, Xu M, Xu Y, Li M, et al. Active smoking, passive smoking, and risk of nonalcoholic fatty liver disease (NAFLD): a population-based study in China. J Epidemiol. 2013;23(2):115-21.

Yang G, Wang Y, Wu Y, Yang J, Wan X. The road to effective tobacco control in China. Lancet. 2015;385(9972):1019-28.

Downloads

Published

2024-09-02

How to Cite

Khoso, A. R., Jintu, G., Bhutto, S., Li, L., & Ujuagu, F. L. (2024). China’s tobacco smoking epidemic: prevalence, illness load, obstacles, and future plans. Pakistan Journal of Chest Medicine, 30(3), 390–396. Retrieved from http://pjcm.net/index.php/pjcm/article/view/869

Issue

Section

Review Article